CASE STUDY: Accelerated Interim Analysis in a Phase II ALS Trial

Rare Disease

CASE STUDY: Accelerated Interim Analysis in a Phase II ALS Trial

June 06, 2026

How Stiris delivered a rapid operational response to meet an accelerated interim analysis in a Phase II Amyotrophic Lateral Sclerosis (ALS) study, without compromising data quality.

CASE STUDY: Stiris Research Stabilizes Site Performance to Protect a Phase IIa ALS Trial Milestone

May 05, 2026

CASE STUDY: How Proactive Data Management and Site Enablement Accelerated a Phase IIa ALS Trial

March 03, 2026

CASE STUDY: Accelerated Interim Analysis in a Phase II ALS Trial

Rare Disease

CASE STUDY: Accelerated Interim Analysis in a Phase II ALS Trial

CASE STUDY: Stiris Research Stabilizes Site Performance to Protect a Phase IIa ALS Trial Milestone

CASE STUDY: How Proactive Data Management and Site Enablement Accelerated a Phase IIa ALS Trial

We have your back

When we collaborate, you’ll get to take a vacation, and actually enjoy it.

Stiris USA

Stiris Canada